Therini Bio Announces Interim Results from the Phase 1
- THN391 was found to be safe and well-tolerated -- THN391 demonstrated a prolonged half-life and dose proportional Cmax levels -- The data will be...
Source: globenewswire.com
Stay updated with breaking news from Beyond Amyloid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- THN391 was found to be safe and well-tolerated -- THN391 demonstrated a prolonged half-life and dose proportional Cmax levels -- The data will be...
-Webinar to discuss investigational strategies to improve symptoms in Alzheimer's disease patients - Friday, September 30th @ 11:15 a.m. EDT LOS ANGELES,...